Floatz logo

INTERFERON ALPHA 1B

Thalidomide

Henan Cancer Hospitalprotein_peptideN/AActive
D
30/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
15/ 100
Competitive Position
89/ 100

Competitive context

3 Active assets in the Thalidomide cohort.

Asset / SponsorPhaseRating
PREDNISONE TABLETS
Fudan University
Phase 3B
IMMUNOGLOBULIN G 1 (HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .GAMMA.1-CHAIN ANTI-HUMAN ANTIGEN CD 20), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .KAPPA.-CHAIN, DIMER
Fudan University
Phase 3B
Inno-206
Fudan University
Phase 3B
Cyclophosphamide
Fudan University
Phase 3B
(+)-VINCRISTINE
Fudan University
Phase 3B

View all 9 →

Same molecule, other indications

INTERFERON ALPHA 1B is also rated in:

Maintenance TreatmentDormant
D
Indicative ·
30 / 100
View asset →
Minor Residue DiseaseDormant
D
Indicative ·
30 / 100
View asset →
Interferon-α-1bDormant
D
Indicative ·
30 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →